D. E. Shaw & Co »

Halozyme Therapeutics shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2013-03-31 $646k 112k 5.77
2012-12-31 $102k 15k 6.74
2012-03-31 $422k 33k 12.76
2011-12-31 $527k 55k 9.53
2011-09-30 $81k 13k 6.11

More positions owned by D. E. Shaw & Co

Apple Put Option (AAPL)
Microsoft Corporation Put Option (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A Call Option (META)
Broadcom Call Option (AVGO)
Tesla Motors (TSLA)
Chipotle Mexican Grill (CMG)
Netflix Put Option (NFLX)
Visa Com Cl A (V)
Adobe Systems Incorporated (ADBE)
Advanced Micro Devices Put Option (AMD)
Citigroup Com New (C)
Crowdstrike Hldgs Cl A Put Option (CRWD)
Booking Holdings (BKNG)

View all positions for D. E. Shaw & Co

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Artisan Partners Limited Partnership
Alliancebernstein
Macquarie Group
Jpmorgan Chase & Co
Geode Capital Management
TD Asset Management
Invesco
Jennifer Ranahan
Arrowpoint Asset Management
Dimensional Fund Advisors
Bank of America Corporation

View all funds holding Halozyme Therapeutics